Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
6-deoxy-6-iodo-D-glucose PET imaging in healthy volunteers
2013-003526-92Phase 2Completed
- Sponsor
- Inserm
- Start
- Dec 2013
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of 6-deoxy-6-iodo-D-glucose in None, sponsored by Inserm. Primary endpoint: Primary imaging and safety endpoints. Started Dec 2013; status: completed.
02
Drugs
6-deoxy-6-iodo-D-glucose
Beyond the preview
Go deeper on 2013-003526-92.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003526-92.